Pacific Biosciences Of California (PACB) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -539.00 |
| Dec 31, 2025 | -4,408.00 |
| Sep 30, 2025 | -1,103.00 |
| Jun 30, 2025 | 2,136.00 |
| Mar 31, 2025 | 9,092.00 |
| Dec 31, 2024 | 6,591.00 |
| Sep 30, 2024 | 7,640.00 |
| Jun 30, 2024 | 5,710.00 |
| Mar 31, 2024 | 6,083.00 |
| Dec 31, 2023 | 4,809.00 |
| Sep 30, 2023 | 4,593.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 5,153.00 |
| Dec 31, 2022 | 5,330.00 |
| Sep 30, 2022 | 4,719.00 |
| Jun 30, 2022 | 5,441.00 |
| Mar 31, 2022 | 6,386.00 |
| Jun 30, 2021 | 2,008.00 |
| Mar 31, 2021 | 1,420.00 |
| Dec 31, 2020 | 495.00 |
| Sep 30, 2020 | -37.00 |
| Jun 30, 2020 | -1,848.00 |
| Mar 31, 2020 | -9,056.00 |
| Dec 31, 2019 | -3,403.00 |
| Sep 30, 2019 | -4,052.00 |
| Jun 30, 2019 | -1,648.00 |
| Mar 31, 2019 | -1,593.00 |
| Dec 31, 2018 | -386.00 |
| Sep 30, 2018 | 222.00 |
| Mar 31, 2017 | -2,025.00 |
| Dec 31, 2016 | -1,191.00 |
| Sep 30, 2016 | 1,019.00 |